These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 12697643

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Prolonged exposure of methicillin-resistant Staphylococcus aureus (MRSA) COL strain to increasing concentrations of oxacillin results in a multidrug-resistant phenotype.
    Martins A, Couto I, Aagaard L, Martins M, Viveiros M, Kristiansen JE, Amaral L.
    Int J Antimicrob Agents; 2007 Mar; 29(3):302-5. PubMed ID: 17276037
    [Abstract] [Full Text] [Related]

  • 43. Activity of ciprofloxacin and azithromycin on biofilms produced in vitro by Haemophilus influenzae.
    Wang D, Wang Y, Liu YN.
    Chin Med J (Engl); 2009 Jun 05; 122(11):1305-10. PubMed ID: 19567142
    [Abstract] [Full Text] [Related]

  • 44. Reversal of resistance in microorganisms by help of non-antibiotics.
    Kristiansen JE, Hendricks O, Delvin T, Butterworth TS, Aagaard L, Christensen JB, Flores VC, Keyzer H.
    J Antimicrob Chemother; 2007 Jun 05; 59(6):1271-9. PubMed ID: 17403708
    [Abstract] [Full Text] [Related]

  • 45. Bactericidal activity and target preference of a piperazinyl-cross-linked ciprofloxacin dimer with Staphylococcus aureus and Escherichia coli.
    Zhao X, Quinn B, Kerns R, Drlica K.
    J Antimicrob Chemother; 2006 Dec 05; 58(6):1283-6. PubMed ID: 17003060
    [Abstract] [Full Text] [Related]

  • 46. Boronic species as promising inhibitors of the Staphylococcus aureus NorA efflux pump: study of 6-substituted pyridine-3-boronic acid derivatives.
    Fontaine F, Héquet A, Voisin-Chiret AS, Bouillon A, Lesnard A, Cresteil T, Jolivalt C, Rault S.
    Eur J Med Chem; 2015 May 05; 95():185-98. PubMed ID: 25817769
    [Abstract] [Full Text] [Related]

  • 47. In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
    Higa F, Akamine M, Haranaga S, Tohyama M, Shinzato T, Tateyama M, Koide M, Saito A, Fujita J.
    J Antimicrob Chemother; 2005 Dec 05; 56(6):1053-7. PubMed ID: 16260445
    [Abstract] [Full Text] [Related]

  • 48. In vitro antimicrobial activity of orbifloxacin against Staphylococcus intermedius isolates from canine skin and ear infections.
    Ganière JP, Médaille C, Etoré F.
    Res Vet Sci; 2004 Aug 05; 77(1):67-71. PubMed ID: 15120955
    [Abstract] [Full Text] [Related]

  • 49. Bacterial efflux pump inhibitors from natural sources.
    Stavri M, Piddock LJ, Gibbons S.
    J Antimicrob Chemother; 2007 Jun 05; 59(6):1247-60. PubMed ID: 17145734
    [Abstract] [Full Text] [Related]

  • 50. Pharmacodynamic activity of garenoxacin against ciprofloxacin-resistant Streptococcus pneumoniae.
    Zhanel GG, James J, Derkatch S, Laing N, Noreddin AM, Hoban DJ.
    J Antimicrob Chemother; 2006 Jul 05; 58(1):112-6. PubMed ID: 16644764
    [Abstract] [Full Text] [Related]

  • 51. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
    Pasquali F, Manfreda G.
    Vet Microbiol; 2007 Jan 31; 119(2-4):304-10. PubMed ID: 16987619
    [Abstract] [Full Text] [Related]

  • 52. [Azithromycin, pharmacodynamic evaluation in animal models].
    Lagrange PH.
    Pathol Biol (Paris); 1995 Jun 31; 43(6):515-23. PubMed ID: 8539074
    [Abstract] [Full Text] [Related]

  • 53. Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems.
    Mizunaga S, Kamiyama T, Fukuda Y, Takahata M, Mitsuyama J.
    J Antimicrob Chemother; 2005 Jul 31; 56(1):91-6. PubMed ID: 15890721
    [Abstract] [Full Text] [Related]

  • 54. Clinical resistance of Staphylococcus keratitis to ciprofloxacin monotherapy.
    Sharma V, Sharma S, Garg P, Rao GN.
    Indian J Ophthalmol; 2004 Dec 31; 52(4):287-92. PubMed ID: 15693319
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Enhanced killing of intracellular multidrug-resistant Mycobacterium tuberculosis by compounds that affect the activity of efflux pumps.
    Amaral L, Martins M, Viveiros M.
    J Antimicrob Chemother; 2007 Jun 31; 59(6):1237-46. PubMed ID: 17218448
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.